These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10211545)

  • 1. Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer.
    Possinger K; Kaufmann M; Coleman R; Stuart NS; Helsing M; Ohnmacht U; Arning M
    Anticancer Drugs; 1999 Feb; 10(2):155-62. PubMed ID: 10211545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-agent gemcitabine is active in previously treated metastatic breast cancer.
    Spielmann M; Llombart-Cussac A; Kalla S; Espié M; Namer M; Ferrero JM; Diéras V; Fumoleau P; Cuvier C; Perrocheau G; Ponzio A; Kayitalire L; Pouillart P
    Oncology; 2001; 60(4):303-7. PubMed ID: 11408796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced breast cancer: a phase II trial with gemcitabine.
    Carmichael J; Possinger K; Phillip P; Beykirch M; Kerr H; Walling J; Harris AL
    J Clin Oncol; 1995 Nov; 13(11):2731-6. PubMed ID: 7595731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine in advanced breast cancer.
    Possinger K
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():55-9. PubMed ID: 8718426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.
    Hausmaninger H; Morack G; Heinrich B; Wallwiener D; Höffken K; Buksmaui S; Krejcy K; Miller MA; Possinger K
    Am J Clin Oncol; 2004 Aug; 27(4):429-35. PubMed ID: 15289740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II activity of gemcitabine in advanced breast cancer.
    Carmichael J; Walling J
    Semin Oncol; 1996 Oct; 23(5 Suppl 10):77-81. PubMed ID: 8893887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.
    Akrivakis K; Schmid P; Flath B; Schweigert M; Sezer O; Mergenthaler HG; Possinger K
    Anticancer Drugs; 1999 Jul; 10(6):525-31. PubMed ID: 10885899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial.
    Schmid P; Krocker J; Schulz CO; Michniewicz K; Dieing A; Eggemann H; Heilmann V; Blohmer JU; Sezer O; Elling D; Possinger K
    Anticancer Drugs; 2005 Jan; 16(1):21-9. PubMed ID: 15613900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial.
    Blackstein M; Vogel CL; Ambinder R; Cowan J; Iglesias J; Melemed A
    Oncology; 2002; 62(1):2-8. PubMed ID: 11810037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes.
    Salman HS; Tanaka K; Sparano JA
    Clin Breast Cancer; 2002 Jan; 2(4):299-303. PubMed ID: 11899362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer: results of a multicenter phase II study.
    Palmeri S; Vaglica M; Spada S; Filippelli G; Farris A; Palmeri L; Massidda B; Misino A; Ferraù F; Comella G; Leonardi V; Condemi G; Mangiameli A; De Cataldis G; Macaluso MC; Cajozzo M; Iannitto E; Danova M
    Oncology; 2005; 68(4-6):438-45. PubMed ID: 16020974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.
    Modi S; Currie VE; Seidman AD; Bach AM; Panageas KS; Theodoulou M; Moasser MM; D'Andrea GM; Lake DE; Choi J; Norton L; Hudis CA
    Clin Breast Cancer; 2005 Apr; 6(1):55-60. PubMed ID: 15899073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial.
    Van Kooten M; Traine G; Cinat G; Cazap E; Comba AZ; Vicente H; Sena S; Nievas OR; Orlando M
    Br J Cancer; 1999 Nov; 81(5):846-9. PubMed ID: 10555756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.
    Brugnatelli S; Danova M; De Bella MT; Vaglica M; Manuguerra G; Riccardi A; Palmeri S
    Oncology; 2002; 62(1):33-8. PubMed ID: 11810041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.
    Halim A; Wahba H
    Med Oncol; 2012 Jun; 29(2):454-8. PubMed ID: 21350875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study.
    Lüftner D; Flath B; Akrivakis C; Mergenthaler HG; Ohnmacht U; Arning M; Possinger K
    Invest New Drugs; 1998; 16(2):141-6. PubMed ID: 9848577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.
    Demiray M; Kurt E; Evrensel T; Kanat O; Arslan M; Saraydaroglu O; Ercan I; Gonullu G; Gokgoz S; Topal U; Tolunay S; Tasdelen I; Manavoglu O
    Cancer Invest; 2005; 23(5):386-91. PubMed ID: 16193637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.
    Sanal SM; Gokmen E; Karabulut B; Sezgin C
    Breast J; 2002; 8(3):171-6. PubMed ID: 12047474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel and gemcitabine as salvage treatment in metastatic breast cancer.
    Murad AM
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):26-32. PubMed ID: 14768402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
    Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.